TCM
HALO icon

Teza Capital Management’s Halozyme HALO Stock Holding History

Teza Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,976
Closed -$573K – 394
2025
Q1 		$573K Buy
+8,976
New +$521K 0.26% 128
2024
Q2 		– Sell
-5,996
Closed -$244K – 650
2024
Q1 		$244K Buy
5,996
+146
+2% +$5.47K 0.03% 476
2023
Q4 		$216K Buy
+5,850
New +$220K 0.04% 485
2021
Q3 		– Sell
-7,792
Closed -$354K – 441
2021
Q2 		$354K Buy
+7,792
New +$345K 0.06% 399

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Teza Capital Management's HALO Position: Q2 2025 in Review

Teza Capital Management sold out of Halozyme (HALO) in Q2 2025, closing a stake of 8,976 shares — an estimated $573K sold.

Teza Capital Management first reported a position in HALO in Q2 2021 and held it in 4 quarters. The position peaked at $573K in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Teza Capital Management reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Teza Capital Management sold 8,976 Halozyme shares in Q2 2025, an estimated $573K.
  • Teza Capital Management first reported a position in Halozyme in Q2 2021 and held it in 4 quarters.
  • Teza Capital Management's Halozyme position peaked at $573K in Q1 2025.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Teza Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.